Xilio Therapeutics, Inc. (NASDAQ:XLO) IPO
IPO
Priced at US$16.00 a share on Oct 21, 2021.
- Price
- US$16.00 a share
- Shares offered
- 7,353,000 shares of common stock
- Offering size
- US$117.6 million
- Underwriters' option
- Up to 1,102,950 more shares
- Listing
- XLO on the Nasdaq Global Select Market
- Underwriters
- MORGAN STANLEY, COWEN, GUGGENHEIM SECURITIES, RAYMOND JAMES · In the order on the cover
- Shares delivered
- On or about Oct 26, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | May 24, 2021 |
| Filed publicly | Oct 1, 2021 |
| Amended twice | Newest Oct 20, 2021 |
| Shares registered with an exchange | Oct 18, 2021 |
| Declared effective by the SEC | Oct 21, 2021 |
| Final prospectus, with the price | Oct 22, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 22, 2021 |
| EFFECT · Notice that a registration is effective | Oct 21, 2021 |
| CERT · Exchange's certificate of listing | Oct 21, 2021 |
| S-1/A · Registration statement, amended | Oct 20, 2021 |
| CORRESP · Letter to the SEC | Oct 19, 2021 |
| CORRESP · Letter to the SEC | Oct 19, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 18, 2021 |
| CORRESP · Letter to the SEC | Oct 18, 2021 |
| S-1/A · Registration statement, amended | Oct 18, 2021 |
| UPLOAD · Letter from the SEC | Oct 13, 2021 |
| CORRESP · Letter to the SEC | Oct 1, 2021 |
| S-1 · Registration statement | Oct 1, 2021 |
| UPLOAD · Letter from the SEC | Sep 23, 2021 |
| DRSLTR · Letter to the SEC with a draft | Sep 14, 2021 |
| DRS/A · Draft registration statement, amended | Sep 14, 2021 |
| UPLOAD · Letter from the SEC | Jun 21, 2021 |
| DRS · Draft registration statement | May 24, 2021 |
From the cover of the final prospectus (424B4) filed Oct 22, 2021